Cure AHC awards $33,000 Grant to Aarhus University (Denmark)

Latest Cure AHC Research Funding

Targets Treatment of Cognitive Impairment in Alternating Hemiplegia of Childhood

RALEIGH, NC, UNITED STATES, October 16, 2017 /EINPresswire.com/ — Cure AHC, Inc. has awarded a grant of $33,000 to. Karin Lykke-Hartmann, Ph.D., of Aarhus University in Denmark for her project “Neuroelectrophysiological Study of D801Y Mouse Model, Cognition and Learning Focus”. The 4 month project will involve understanding how the plasticity of the neurons contribute towards the cognitive performance in the D801Y mutation of the gene ATP1A3. Findings from this study may be useful for future pharmacological treatments.

“We are hopeful that this project will fill in some key gaps in knowledge about AHC and propel us forward with candidates for treatment,” said Dr. Lykke-Hartmann.

“Cure AHC recognizes that cognition/learning poses one of the biggest barriers to those with AHC functioning fully in society. We are hopeful this research will go a long way towards eliminating this symptom of AHC.” said Cure AHC Co-Founder and President Jeff Wuchich. Cure AHC plans to fund several other collaborative and complementary research projects in 2017 and 2018, with an aim to raise $600,000 USD.

Alternating Hemiplegia of Childhood (AHC) is a currently incurable, rare and painful neurological disorder that causes episodes of temporary paralysis that last minutes or even days. AHC is often mistaken for cerebral palsy or epilepsy, which impairs the ability to learn and communicate. AHC also affects muscle control, causing shallow breathing and difficulty walking and swallowing. Researchers discovered the gene that causes Alternating Hemiplegia of Childhood (AHC) in 2012 and they continue to make progress in their understanding of the disease, which aids in better treatment and ultimately a cure for AHC sufferers, as well as potential benefit to more mainstream diseases such as epilepsy, stroke, and heart disease.

Cure AHC is a global 501 (c) 3 Non-profit organization created to raise awareness and research funds to develop a treatment and discover the cure for Alternating Hemiplegia of Childhood. Donations to Cure AHC can be made online through the www.cureahc.org donation page or a check may be sent to Cure AHC, Inc. at 8480 Honeycutt RD, #200 Raleigh, NC 27615. Please visit www.cureahc.org or email info@cureahc.org for more information. To reach Karin Lykke-Hartmann, email Karin at kly@biomed.au.dk.

Jeff Wuchich
Cure AHC
919.412.1870
email us here


Source: EIN Presswire

Former Intelligence & Defense Officials Are Preparing Citizens For Disclosure of Extraterrestrial Intelligence

The Disclosure Activists have witnessed a major step in the ET Disclosure effort after years of government inquiries, lobbying, public outreach, & speculation.

SEATTLE, WASHINGTON, UNITED STATES, October 16, 2017 /EINPresswire.com/ — The Disclosure Activists have witnessed a major step in the formal Disclosure effort after years of government inquiries, lobbying, public outreach, and speculation. Last week it was acknowledged by recently retired Intelligence & Defense officials that the UFO/UAP (Unidentified Aerial Phenomenon) are in fact, real. There is now a public, transparent group of former government insiders leading open research into their existence and the exotic, advanced technology used in their craft.

We believe these revelations are part of a well-orchestrated plan by elements formerly and currently within the U.S. government who are seeking formal Disclosure of the extraterrestrial presence that has been engaging our planet for decades. There are similar efforts underway in many countries around the globe. Several U.S. organizations that have played a role in this international Disclosure effort, including Paradigm Research Group (PRG) headed by Stephen Bassett, the Disclosure Project founded by Dr Steven Greer, and the Institute for Exoconsciousness, founded by Dr. Rebecca Hardcastle Wright (also a strategic adviser for The Disclosure Activists), who worked closely with astronaut Dr. Edgar Mitchell.

Several stunning admissions were made during a presentation led by Tom Delonge, founder of the rock bands Blink-182 and Angels and Airwaves and a notable UFO researcher himself, as well as a uniquely well-informed group of advisers. In addition to authoring books like Sekret Machines (co-authored with Peter Levenda and Paolo Costanzo), DeLonge has become an outspoken and prolific voice for the reality of the extraterrestrial phenomenon going back decades. There are dozens of radio interviews and YouTube videos with Mr. Delonge, who initially promised he was “working with a group of military and D.C. handlers to bring this out to the public”. These statements were validated several months later by the content of the John Podesta emails published by Wikileaks. The veracity of those emails has been confirmed by the Institute for Exoconsciousness.

In the presentation, DeLonge announced the launch of the To The Stars Academy of Arts & Science, a public benefit corporation designed to advance the research of UAP and related technology. Their mission also includes entertainment and media outreach efforts, like TV shows and feature films based on emerging ‘science fact’.

Also in attendance were the following distinguished members of the new corporation:
Jim Semivan — Former CIA Directorate of Operations
Dr. Hal Puthoff — Theoretical Physicist, CIA Psychic Spy Program, Space Time Scientist
Steve Justice — Former Director of Advanced Systems at Lockheed Martin Skunkworks — recently departed Lockheed.
Lou Elizondo — Dept of Defense, Office of the Sec of Defense, Senior Covert Intelligence Office, left just days before the release.
Chris Mellon — Deputy Assistant Sec of Defense for Intelligence, Minority Staff Director for Senate Intelligence Committee

The Disclosure Activists co-founder Russell Calka said:
‘It was revealed today that former Intelligence officials from the CIA and DoD have confirmed the existence of exotic technology powering UAPs — and that this technology not only defies our current understanding of physics, but also is not known to ANY Government-body on the planet. The team mentioned above has formed a private organization and it appears have struck a deal with Pentagon officials and the US Government so that the private sector can start allowing this information to flow out for all.’

Co-Founder Dr. Lisa Galarneau stated:
‘I believe the access DeLonge has been given, apparent in the team of intelligence, defense, and aerospace veterans he’s assembled — makes it clear there is government cooperation happening. He is a well-known figure in popular culture and well positioned to launch a renaissance in science fiction based on science fact. This is critical to public outreach efforts as he attracts and has access to large audiences. They have also announced plans to release curated government assets (declassified documents, photos, videos, etc.) of legitimate UAP events, as well as plans for advanced aerospace vehicles to the public. They even plan to build a craft themselves, according to their statements. This is a big deal considering their connections to Lockheed Martin Skunkworks and other organizations rumored to be working on such technology for decades at this point.’

Extended Release:
https://medium.com/we-are-not-alone-the-disclosure-lobby/former-intelligence-and-defense-officials-are-preparing-citizens-for-disclosure-of-extraterrestrial-981296506603

The Disclosure Activists
http://www.DisclosureActivists.org

Lisa Galarneau
The Disclosure Activists
206 503 3369
email us here


Source: EIN Presswire

Hear from ProQR Therapeutics: RNA Therapeutics for Patients with Cystic Fibrosis

All presentations were of excellent quality, timekeeping was perfect”

— GSK

LONDON, UNITED KINGDOM, October 16, 2017 /EINPresswire.com/ — SMi are thrilled to welcome Dr. Noreen Roth Henig, Chief Medical Officer, ProQR Therapeutics onto the speaker panel RNA Therapeutics 2018! www.therapeutics-rna.com/ein

ProQR is dedicated to discovering and developing RNA therapeutics for severe genetic rare diseases. Their QR-010 molecule is designed to address the most common mutation which causes cystic fibrosis. It has now demonstrated safety and clinical activity in two early clinical trials. This program integrated a creative approach to preclinical data, delivery, and clinical trial design to quickly advance this potential RNA therapeutic for a significant orphan disease population. Using a similar creative approach, ProQR have developed their second molecule, QR-110 for individuals with Leber’s congential amaurosis Type 10 into a now on-going clinical trial. Beyond that, have a pipeline of RNA therapeutics.

In the last several years, the RNA-based therapeutic development field has made good on the promise of decades of preclinical research. There are some outstanding and creative clinical trials using RNA-based therapeutics and strong momentum to bring these RNA-based therapeutics to patients.

For the detailed interview, check out the download centre online.

"I will share the challenges and choices made in bringing these molecules to development using QR-010 as the key example as it is farthest along."
– Noreen Roth Henig

Hear more from Dr. Henig at RNA Therapeutics this February 2018, as she presents 'RNA Therapeutics for Patients with Cystic Fibrosis: QR-010 and Beyond'

For those looking to attend there is currently a £400 early-bird saving, ending October 31st

Further information is available at: www.therapeutics-rna.com/ein

SMi presents the 9th Annual Conference:
RNA Therapeutics
Date: 21st – 22nd February 2018
Location: Holiday Inn London – Kensington Forum
Website: www.therapeutics-rna.com/ein

—end—

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Pav Solanki
SMi Group
2078276048
email us here


Source: EIN Presswire

Global Medical Transcription Software Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2022

Medical Transcription Software Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022

PUNE, INDIA, October 16, 2017 /EINPresswire.com/ —

Summary

WiseGuyReports.com adds “Medical Transcription Software Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database.

This report provides in depth study of “Medical Transcription Software market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Pasta Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Medical Transcription Software market, analyzes and researches the Medical Transcription Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like 
Nagarsoft 
Nuance 
EvolveMed 
ZyDoc 
NCH Software 
Acusis 
ZyDoc Transcription 
SmartMD 
eCareNotes Transcription Workflows 
Narratek 
Entrada 
Winscribe 
LCD Solutions

Request a Sample Report @   https://www.wiseguyreports.com/sample-request/2390382-global-medical-transcription-software-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers 
United States 
EU 
Japan 
China 
India 
Southeast Asia

Market segment by Type, Medical Transcription Software can be split into 
Cloud, SaaS, Web 
Installed – Windows 
Mobile – iOS Native

Market segment by Application, Medical Transcription Software can be split into 
Hospital 
Clinic 
Others

At any Query @ https://www.wiseguyreports.com/enquiry/2390382-global-medical-transcription-software-market-size-status-and-forecast-2022

Table of Contents 

Global Medical Transcription Software Market Size, Status and Forecast 2022 
1 Industry Overview of Medical Transcription Software 
1.1 Medical Transcription Software Market Overview 
1.1.1 Medical Transcription Software Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Medical Transcription Software Market Size and Analysis by Regions 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 Medical Transcription Software Market by Type 
1.3.1 Cloud, SaaS, Web 
1.3.2 Installed – Windows 
1.3.3 Mobile – iOS Native 
1.4 Medical Transcription Software Market by End Users/Application 
1.4.1 Hospital 
1.4.2 Clinic 
1.4.3 Others

2 Global Medical Transcription Software Competition Analysis by Players 
2.1 Medical Transcription Software Market Size (Value) by Players (2016 and 2017) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Nagarsoft 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.1.5 Recent Developments 
3.2 Nuance 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.2.5 Recent Developments 
3.3 EvolveMed 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.3.5 Recent Developments 
3.4 ZyDoc 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.4.5 Recent Developments 
3.5 NCH Software 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.5.5 Recent Developments 
3.6 Acusis 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.6.5 Recent Developments 
3.7 ZyDoc Transcription 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.7.5 Recent Developments 
3.8 SmartMD 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.8.5 Recent Developments 
3.9 eCareNotes Transcription Workflows 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.9.5 Recent Developments 
3.10 Narratek 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Medical Transcription Software Revenue (Value) (2012-2017) 
3.10.5 Recent Developments 
3.11 Entrada 
3.12 Winscribe 
3.13 LCD Solutions

4 Global Medical Transcription Software Market Size by Type and Application (2012-2017) 
4.1 Global Medical Transcription Software Market Size by Type (2012-2017) 
4.2 Global Medical Transcription Software Market Size by Application (2012-2017) 
4.3 Potential Application of Medical Transcription Software in Future 
4.4 Top Consumer/End Users of Medical Transcription Software

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2390382

Continued….

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Exceptional speaker line-up for Ophthalmic Drugs

Ophthalmic Drugs 2017

Hear from Santen, Novaliq GmBh, Aptar Pharma and more

LONDON, UNITED KINGDOM, October 16, 2017 /EINPresswire.com/ — Only 6 weeks remain until Europe's Leading Ophthalmic Drugs Conference and here is why you cannot afford to miss out! www.ophthalmicdrugs.com/ein

With incredible representation from our pharma industry experts, they will help tackle every possible obstacle you may face through real-life case studies. Gain insight into latest approaches in key areas such as ocular diseases, drug delivery, pre-clinical and clinical trials, computer technologies and therapies for diabetic macular oedema.

Agenda highlights will include a spotlight on therapies for glaucoma, development of efficient drug delivery systems and current trends in novel non- surgical interventions.

Spotlight:

Minimally Invasive Glaucoma Surgery for various glaucoma treatments will address the use of conjugate drugs and a new prostaglandin drug product co-developed by Santen, called 'Omidenepag Isopropyl.' – Naj Sharif, Executive Director in R&D, Head, Global Alliances & External Research, Santen Inc

Non-Aqueous, preservative-free ocular drug delivery technology with unique properties:

One of the biggest challenges currently facing the pharmaceutical industry is the development of more efficient drug delivery systems. For instance, the anterior part of the eye is amongst the most readily accessible organs, in terms of location in the human body; however, drug delivery to eye tissue is particularly problematic. This is reflected by the notoriously poor bioavailability of topical ocular drug formulations of 5% or less. – Bernhard Guenther, Co-Founder, Chief Innovation Officer, Novaliq GmbH

New Technologies in Ophthalmic Drug Delivery:

Poor Patient Compliance is a major impediment to effective treatments in eye care. By bringing in new technologies will help ease the situation and enable patients to become comfortable during treatment. Also, monitoring systems for clinical trials are a revolutionary method to ease work of clinicians and make clinical data more reliable. Other factors to be discussed are the novel drug delivery systems and how they can contribute to patient adherence, which have been approved by the FDA. – Matthias Birkhoff, Vice President Business Development, Aptar Pharma

Companies Attending:

Santen Inc, Shire, Novartis, Roche, NightstaRx, Aerie Pharmaceuticals, Bayer, Envisia Therapeutics, Boehringer Ingelheim, Oxford BioMedica, Novaliq GmbH, Alimera Sciences, Aptar Pharma and PharmaMedic Consultancy Ltd and more.

Booked Last Week:

Biozep AS, NanOptima Limited, Ora Inc and Roche

Further information is available at: www.ophthalmicdrugs.com/ein

For those looking to attend there is currently a £100 early-bird saving by October 31st

SMi Presents the Launch of…
Ophthalmic Drugs
Date: 28th – 29th November 2017
Location: Kensington, London
Website: www.ophthalmicdrugs.com/ein

Sponsored by: Leica Microsystems | Experimentica

—end—

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Pav Solanki
SMi Group
2078276048
email us here


Source: EIN Presswire

Wireless Computer Speakers Market Analysis 2017 (By Segment, Key Players and Applications) and Forecasts To 2022

Wireless Computer Speakers Global Market Share, Opportunities, Segmentation and Forecast to 2022

PUNE, INDIA, October 16, 2017 /EINPresswire.com/ — Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Wireless Computer Speakers for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Wireless Computer Speakers market competition by top manufacturers/players, with Wireless Computer Speakers sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Creative
JBL (Harman International)
Creative
IPEVO
iLive Electronics (DPI)

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1240595-global-wireless-computer-speakers-sales-market-report-2017

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AirPlay
Bluetooth
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Wireless Computer Speakers for each application, including
PC
Mac
Notebook
Other
Table of Content: Key Points

Global Wireless Computer Speakers Sales Market Report 2017
1 Wireless Computer Speakers Market Overview
1.1 Product Overview and Scope of Wireless Computer Speakers
1.2 Classification of Wireless Computer Speakers by Product Category
1.2.1 Global Wireless Computer Speakers Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Wireless Computer Speakers Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 AirPlay
1.2.4 Bluetooth
1.2.5 Other
1.3 Global Wireless Computer Speakers Market by Application/End Users
1.3.1 Global Wireless Computer Speakers Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 PC
1.3.3 Mac
1.3.4 Notebook
1.3.5 Other
1.4 Global Wireless Computer Speakers Market by Region
1.4.1 Global Wireless Computer Speakers Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Wireless Computer Speakers Status and Prospect (2012-2022)
1.4.3 China Wireless Computer Speakers Status and Prospect (2012-2022)
1.4.4 Europe Wireless Computer Speakers Status and Prospect (2012-2022)
1.4.5 Japan Wireless Computer Speakers Status and Prospect (2012-2022)
1.4.6 Southeast Asia Wireless Computer Speakers Status and Prospect (2012-2022)
1.4.7 India Wireless Computer Speakers Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Wireless Computer Speakers (2012-2022)
1.5.1 Global Wireless Computer Speakers Sales and Growth Rate (2012-2022)
1.5.2 Global Wireless Computer Speakers Revenue and Growth Rate (2012-2022)

9 Global Wireless Computer Speakers Players/Suppliers Profiles and Sales Data
9.1 Creative
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Wireless Computer Speakers Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Creative Wireless Computer Speakers Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 JBL (Harman International)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Wireless Computer Speakers Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 JBL (Harman International) Wireless Computer Speakers Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Creative
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Wireless Computer Speakers Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Creative Wireless Computer Speakers Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 IPEVO
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Wireless Computer Speakers Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 IPEVO Wireless Computer Speakers Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 iLive Electronics (DPI)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Wireless Computer Speakers Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 iLive Electronics (DPI) Wireless Computer Speakers Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1240595-global-wireless-computer-speakers-sales-market-report-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

How Doctors’ Conversations Differ From Private to Public Social Networks?

Only at Social Media in Pharma

It was a great event. Very thought provoking. Liked to hear the new ideas + understand how social media can continue to be intergrated”

— Eli Lilly

LONDON, UNITED KINGDOM, October 16, 2017 /EINPresswire.com/ — SMi are thrilled to welcome Adam Doggett, Senior Research Analyst, CREATION onto the speaker panel for their 10th annual Social Media in Pharma conference! www.social-media-pharma.com/ein

Adam's expertise lies in engaging with Online Healthcare Professional (HCP) conversations in order to understand how healthcare and pharmaceutical interventions can be more effective at meeting the needs of HCPs and their patients.

The Senior Research Analyst will present on Day 2 and explain the differences between a public and private network in the context of healthcare, how doctors’ activities and behaviours vary in the 2 spaces and what can be learned from comparing doctor conversations.

"The greatest challenge for the pharmaceutical industry is to get up to speed and start leading the way. Digital innovation moves so quickly and the pharmaceutical industry, with all its resources, should be at the forefront of this change, developing new technologies and ways of thinking."
– Adam Doggett

Hear more from Adam at Social Media in Pharma this January 2018, as he presents 'Interaction in Social Media – How Doctors’ Conversations Differ From Private to Public Social Networks?'

Don't Forget…

Put learnings into practise, with the interactive half-day post-conference workshop, presented by LucidQuest on the 24th January 2018 at, 08:30am – 12:30pm.

The workshop will focus on how stakeholders can combine the latest advancements in Social Media /Social Networking and Strategic Competitive Intelligence in order to uncover opportunities and threats for their companies and brands. Workshop participants will also be provided with a short step-by-step guide on how to integrate SM / SN, and leverage collected data in their competitive intelligence efforts.

Workshop Leaders: Timos Papagatsias, CEO, LucidQuest | Elvira Dragas, Partner, LucidQuest

For more information on all sessions, view the full agenda: www.social-media-pharma.com/ein

For those looking to attend there is currently a £200 early-bird saving by October 31st

SMi Presents the 10th Annual Conference:
Social Media in the Pharmaceutical Industry
Date: 22nd – 23rd January 2017
Location: Kensington, London
Website: www.social-media-pharma.com/ein

—end—

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Pav Solanki
SMi Group
2078276048
email us here


Source: EIN Presswire

Reinsurance in US Market 2017- By Develop Strategies Based on the Latest Regulatory Events

Reinsurance in US Market 2017 – Current and Future Plans

PUNE, INDIA, October 16, 2017 /EINPresswire.com/ — Synopsis
'Reinsurance in the US, Key Trends and Opportunities to 2020' report provides detailed analysis of the market trends, drivers and challenges in the US reinsurance segment.
It provides values for key performance indicators such as written premium, reinsurance ceded and reinsurance accepted during the review period (2011–2015) and forecast period (2015–2020).
The report also analyses information pertaining to the competitive landscape in the country, gives a comprehensive overview of the US economy and demographics, and provides detailed analysis of natural hazards and their impact on the US insurance industry.
The report brings together research, modeling and analysis expertise to enable reinsurers to identify segment dynamics and competitive advantages, and access profiles of reinsurers operating in the country.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1268610-reinsurance-in-the-us-key-trends-and-opportunities-to-2020

Summary
'Reinsurance in the US, Key Trends and Opportunities to 2020' report provides in-depth market analysis, information and insights into the US reinsurance segment, including:

• An outlook of the US reinsurance segment
• A comprehensive overview of the US economy and demographics
• Detailed analysis of natural hazards and their impact on the US insurance industry
• The competitive landscape in the US reinsurance segment

Scope
This report provides a comprehensive analysis of the reinsurance segment in the US:
• It provides historical values for the US reinsurance segment for the report’s 2011–2015 review period, and projected figures for the 2015–2020 forecast period.
• It offers a detailed analysis of the key categories in the US reinsurance segment, and market forecasts to 2020.
• It provides a detailed analysis of the reinsurance ceded from various direct insurance segments in the US, and the reinsurance segment's growth prospects.
• It analyzes various natural and man-made hazards and their impact on the US insurance industry

Reasons to Buy
• Make strategic business decisions using in-depth historic and forecast market data related to the US reinsurance segment, and each category within it.
• Understand the demand-side dynamics, key market trends and growth opportunities in the US reinsurance segment.
• Identify growth opportunities and market dynamics in key product categories.
• Gain insights into key regulations governing the US insurance industry, and their impact on companies and the industry's future.

Key Highlights
• Demand for reinsurance capital increased during the review period, particularly in the property and casualty lines. .
• US multi-peril, US-named storms and hurricanes, and US earthquakes accounted for 53.1% of catastrophe bonds outstanding as of November 2016 .
• The top 10 reinsurers globally, accounted for 83.1% of the total life and non-life gross reinsurance premium in 2016.
• Reinsurance plays a critical role in the US property catastrophe market.

Table of Content: Key Points
1 Key Facts and Highlights
2 Executive Summary
3 Economy and Demographics
4 Reinsurance Outlook
4.1 Reinsurance Segment Size, 2011–2020
4.1.1 Total reinsurance premium accepted
4.2 Reinsurance Segment Size by Premium Ceded, 2011–2020
5 Competitive Landscape
5.1 Company Profiles
5.1.1 National Indemnity Company – company overview
5.1.2 Munich Reinsurance America – company overview
5.1.3 QBE North America – company overview
5.1.4 XL Reinsurance America Inc. – company overview
5.1.5 Swiss Reinsurance America Corporation – company overview
6 Natural and Man-made Hazards
6.1 Storm
6.2 Flooding
6.3 Wildfires
6.4 Earthquakes
6.5 Exposure
7 Definition and Methodology
7.1 Definitions
7.2 Methodology
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1268610-reinsurance-in-the-us-key-trends-and-opportunities-to-2020

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Discover Major Factors Driving Demand For Nickel Mining Market

Pune, India, 16th October 2017: WiseGuyReports announced addition of new report, titled “Global Nickel Mining to 2020”.

PUNE, INDIA, October 16, 2017 /EINPresswire.com/ — The report cover completed exploration of Nickel Mining industry. The report study is based on country and historic and forecast data on nickel production and prices. The report covers factors affecting demand for global nickel and information on the active, exploration and development nickel projects. It also gives and profiles of global leading nickel producing companies.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/753541-global-nickel-mining-to-2020

The major finding in the reports are,
• Extensive information about key work of Nickel mines in Asia-Pacific (APAC), Europe, Oceania, Middle East and Africa (MEA), South and Central America (SCA), North America (NA) and Former Soviet Union (FSU)
• Broad information of major exploration and development nickel projects in APAC, Europe, Oceania, MEA, SCA, NA and FSU.
• Various parameter and product demand that affect the global nickel industry are highlighted in report.
Studying and understand the various major companies working in the world nickel mining industry, with a detail profiling and business information.
Nickel is one of major demanding materials and many countries are going for Nickel mining. Nickel which is commonly known chemical element, they are a silver color element with a few golden shades. They are becoming the vital part of human life in past few years. The Nickel is majorly used for the making steel, stainless Steel, Guitar strings, coins, and batteries, floating green glass.
Finally, the mining sectors are growing rapidly and many countries and region are looking for mining. The technology advancement and industry development with changes of time have also created more demand for mining industries. Nickel has much demand due it alloy material nature, which gives other metals strong, durability, and rusty ness.
The major players cover in the report MMC Norilsk Nickel, Vale SA, Glencore Plc, BHP Billiton Ltd and region covers are Australia, Brazil, New Caledonia, Russia, Philippines.
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/753541-global-nickel-mining-to-2020

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Label-Free Detection Technology Market 2017- Industry Analysis, Size, Share, Growth, Trends and Forecast by 2022

WiseGuyReports.com adds “Label-Free Detection Technology Market 2017 Global Analysis, Opportunities Research Report Forecasting to 2022”reports to its database.

PUNE, INDIA, October 16, 2017 /EINPresswire.com/ — Label-Free Detection Technology Market:

Executive Summary

This report studies the global Label-Free Detection Technology market, analyzes and researches the Label-Free Detection Technology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

General Electric
Danaher Corporation
Perkinelmer
Ametek
Hoffman-La Roche AG
Malvern Panalytical
TA Instruments
Corning Incorporated
Horiba
Shimadzu Corporation
Hitachi High-Technologies Corporation

Request Sample Report @ https://www.wiseguyreports.com/sample-request/2386118-global-label-free-detection-technology-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers

United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Label-Free Detection Technology can be split into

Surface Plasmon Resonance
Bio-layer Interferometry
Isothermal Titration Calorimetry
Differential Scanning Calorimetry
Other Technologies

Market segment by Application, Label-Free Detection Technology can be split into

Pharmaceutical and Biotechnology
Academic Research Institutes
Contract Research Organizations
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/2386118-global-label-free-detection-technology-market-size-status-and-forecast-2022

Table of Contents

Global Label-Free Detection Technology Market Size, Status and Forecast 2022 
1 Industry Overview of Label-Free Detection Technology 
1.1 Label-Free Detection Technology Market Overview 
1.1.1 Label-Free Detection Technology Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Label-Free Detection Technology Market Size and Analysis by Regions 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 Label-Free Detection Technology Market by Type 
1.3.1 Surface Plasmon Resonance 
1.3.2 Bio-layer Interferometry 
1.3.3 Isothermal Titration Calorimetry 
1.3.4 Differential Scanning Calorimetry 
1.3.5 Other Technologies 
1.4 Label-Free Detection Technology Market by End Users/Application 
1.4.1 Pharmaceutical and Biotechnology 
1.4.2 Academic Research Institutes 
1.4.3 Contract Research Organizations 
1.4.4 Others

2 Global Label-Free Detection Technology Competition Analysis by Players 
2.1 Label-Free Detection Technology Market Size (Value) by Players (2016 and 2017) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 

4 Global Label-Free Detection Technology Market Size by Type and Application (2012-2017) 
4.1 Global Label-Free Detection Technology Market Size by Type (2012-2017) 
4.2 Global Label-Free Detection Technology Market Size by Application (2012-2017) 
4.3 Potential Application of Label-Free Detection Technology in Future 
4.4 Top Consumer/End Users of Label-Free Detection Technology

5 United States Label-Free Detection Technology Development Status and Outlook 
5.1 United States Label-Free Detection Technology Market Size (2012-2017) 
5.2 United States Label-Free Detection Technology Market Size and Market Share by Players (2016 and 2017)

6 EU Label-Free Detection Technology Development Status and Outlook 
6.1 EU Label-Free Detection Technology Market Size (2012-2017) 
6.2 EU Label-Free Detection Technology Market Size and Market Share by Players (2016 and 2017)

7 Japan Label-Free Detection Technology Development Status and Outlook 
7.1 Japan Label-Free Detection Technology Market Size (2012-2017) 
7.2 Japan Label-Free Detection Technology Market Size and Market Share by Players (2016 and 2017)

8 China Label-Free Detection Technology Development Status and Outlook 
8.1 China Label-Free Detection Technology Market Size (2012-2017) 
8.2 China Label-Free Detection Technology Market Size and Market Share by Players (2016 and 2017)

9 India Label-Free Detection Technology Development Status and Outlook 
9.1 India Label-Free Detection Technology Market Size (2012-2017) 
9.2 India Label-Free Detection Technology Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Label-Free Detection Technology Development Status and Outlook 
10.1 Southeast Asia Label-Free Detection Technology Market Size (2012-2017) 
10.2 Southeast Asia Label-Free Detection Technology Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022) 
11.1 Global Label-Free Detection Technology Market Size (Value) by Regions (2017-2022) 
11.1.1 United States Label-Free Detection Technology Revenue and Growth Rate (2017-2022) 
11.1.2 EU Label-Free Detection Technology Revenue and Growth Rate (2017-2022) 
11.1.3 Japan Label-Free Detection Technology Revenue and Growth Rate (2017-2022) 
11.1.4 China Label-Free Detection Technology Revenue and Growth Rate (2017-2022) 
11.1.5 India Label-Free Detection Technology Revenue and Growth Rate (2017-2022) 
11.1.6 Southeast Asia Label-Free Detection Technology Revenue and Growth Rate (2017-2022) 
11.2 Global Label-Free Detection Technology Market Size (Value) by Type (2017-2022) 
11.3 Global Label-Free Detection Technology Market Size by Application (2017-2022)

12 Label-Free Detection Technology Market Dynamics 
12.1 Label-Free Detection Technology Market Opportunities 
12.2 Label-Free Detection Technology Challenge and Risk 
12.2.1 Competition from Opponents 
12.2.2 Downside Risks of Economy 
12.3 Label-Free Detection Technology Market Constraints and Threat 
12.3.1 Threat from Substitute 
12.3.2 Government Policy 
12.3.3 Technology Risks 
12.4 Label-Free Detection Technology Market Driving Force 
12.4.1 Growing Demand from Emerging Markets 
12.4.2 Potential Application

13 Market Effect Factors Analysis 
13.1 Technology Progress/Risk 
13.1.1 Substitutes 
13.1.2 Technology Progress in Related Industry 
13.2 Consumer Needs Trend/Customer Preference 
13.3 External Environmental Change 
13.3.1 Economic Fluctuations 
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix 
Methodology 
Analyst Introduction 
Data Source

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2386118

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire